Seeing Is Believing

Currently out of the existing stock ratings of John Ransom, 298 are a BUY (93.13%), 22 are a HOLD (6.88%).
Analyst John Ransom, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 68.51% that have a potential upside of 37.21% achieved within 329 days.
John Ransom’s has documented 596 price targets and ratings displayed on 33 stocks. The coverage is on Healthcare, Consumer Cyclical, Financial Services, Industrials sectors.
Most recent stock forecast was given on OSCR, Oscar Health at 18-Sep-2026.
Analyst best performing recommendations are on CANO (CANO HEALTH).
The best stock recommendation documented was for RDNT (RADNET) at 11/13/2019. The price target of $18.5 was fulfilled within 8 days with a profit of $2.69 (17.01%) receiving and performance score of 21.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 23-Sep-2026
$33
$3.75 (12.82%)
17 days ago
(23-Sep-2026)
8/14 (57.14%)
$4.49 (15.75%)
404
Hold Since 14-May-2025
$32
$2.75 (9.40%)
$25
2 months 10 days ago
(30-Jul-2026)
8/20 (40%)
$3.86 (13.72%)
127
Buy Since 09-Apr-2025
$39
$9.75 (33.33%)
$38
2 months 10 days ago
(30-Jul-2026)
4/7 (57.14%)
$10.86 (38.59%)
135
Buy Since 07-Jan-2025
$36
$6.75 (23.08%)
$30
2 months 26 days ago
(14-Jul-2026)
4/8 (50%)
$4.4 (13.92%)
42
Buy Since 05-Feb-2025
$40
$10.75 (36.75%)
$30
2 months 26 days ago
(14-Jul-2026)
7/12 (58.33%)
$8.4 (26.58%)
186
Which stock is John Ransom most bullish on?
Which stock is John Ransom most reserved on?
What Year was the first public recommendation made by John Ransom?